- Home
- IFRX vs ELTK Comparison
IFRX vs ELTK Comparison
Compare IFRX & ELTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFRX
- ELTK
- Stock Information
- Founded
- IFRX 2007
- ELTK 1970
- Country
- IFRX Germany
- ELTK Israel
- Employees
- IFRX N/A
- ELTK N/A
- Industry
- IFRX Biotechnology: Pharmaceutical Preparations
- ELTK Electrical Products
- Sector
- IFRX Health Care
- ELTK Technology
- Exchange
- IFRX Nasdaq
- ELTK Nasdaq
- Market Cap
- IFRX 65.8M
- ELTK 57.5M
- IPO Year
- IFRX 2017
- ELTK 1997
- Fundamental
- Price
- IFRX $1.30
- ELTK $8.23
- Analyst Decision
- IFRX Strong Buy
- ELTK
- Analyst Count
- IFRX 2
- ELTK 0
- Target Price
- IFRX $9.00
- ELTK N/A
- AVG Volume (30 Days)
- IFRX 322.6K
- ELTK 6.8K
- Earning Date
- IFRX 05-07-2025
- ELTK 05-20-2025
- Dividend Yield
- IFRX N/A
- ELTK 2.21%
- EPS Growth
- IFRX N/A
- ELTK N/A
- EPS
- IFRX N/A
- ELTK 0.63
- Revenue
- IFRX $171,642.00
- ELTK $46,527,000.00
- Revenue This Year
- IFRX $106.72
- ELTK $18.60
- Revenue Next Year
- IFRX $66.89
- ELTK $9.04
- P/E Ratio
- IFRX N/A
- ELTK $13.17
- Revenue Growth
- IFRX 162.79
- ELTK N/A
- 52 Week Low
- IFRX $0.82
- ELTK $7.65
- 52 Week High
- IFRX $2.82
- ELTK $12.47
- Technical
- Relative Strength Index (RSI)
- IFRX 58.32
- ELTK 41.00
- Support Level
- IFRX $0.82
- ELTK $7.83
- Resistance Level
- IFRX $1.12
- ELTK $8.43
- Average True Range (ATR)
- IFRX 0.13
- ELTK 0.34
- MACD
- IFRX 0.06
- ELTK 0.08
- Stochastic Oscillator
- IFRX 90.49
- ELTK 54.72
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About ELTK Eltek Ltd.
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnects. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.